Related Experiment Videos
Bone marrow cell transplantation in clinical perspective
Husnain Kh Haider1, Muhammad Ashraf
1Department of Pathology and Laboratory Medicine, 231-Albert Sabinway, University of Cincinnati, Cincinnati, OH 45267-0529, USA.
Journal of Molecular and Cellular Cardiology
|February 9, 2005
Summary
Bone marrow stem cells show promise for repairing hearts damaged by ischemia. Early studies suggest this regenerative medicine approach is safe and feasible for clinical use.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Stem Cell Biology
Background:
- Ischemic heart damage leads to loss of cardiomyocytes, impairing left ventricular function.
- The heart's intrinsic repair mechanisms are insufficient to restore function after ischemic injury.
- Regenerative medicine offers potential interventions to support cardiac repair.
Purpose of the Study:
- To review the progress of bone marrow stem cell transplantation for cardiac repair.
- To discuss the challenges and controversies in translating this approach to clinical practice.
Main Methods:
- Literature review of preclinical animal studies and phase-1 clinical trials.
- Critical analysis of existing data on bone marrow stem cell therapy for cardiac repair.
Main Results:
- Bone marrow stem cells possess myogenic and angiogenic potential beneficial for cardiac repair.
- Early clinical trials indicate safety and feasibility of bone marrow stem cell transplantation.
- Preclinical and early clinical data are encouraging for this therapeutic strategy.
Conclusions:
- Bone marrow stem cell transplantation is a promising regenerative approach for ischemic heart disease.
- Further research is needed to address existing challenges for widespread clinical application.